134 related articles for article (PubMed ID: 1746705)
21. [Clinical significance of CA125 assay as a tumor marker].
Ariyoshi Y; Kuwabara M; Kuzuya K
Nihon Rinsho; 1990 Feb; 48 Suppl():978-81. PubMed ID: 2192183
[No Abstract] [Full Text] [Related]
22. CA 125 in peritoneal fluid: reliable values at high dilutions.
Barbati A; Anceschi MM; Di Renzo GC; Cosmi EV
Obstet Gynecol; 1992 Jun; 79(6):1011-5. PubMed ID: 1579297
[TBL] [Abstract][Full Text] [Related]
23. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
[TBL] [Abstract][Full Text] [Related]
24. [Clinical evaluation of serum CA-50 and CA 19-9 in gynecological tumors].
Suzuki M; Ohwada M; Tamada T; Sakurabayashi I; Kawai T
Rinsho Byori; 1989 Jul; 37(7):784-8. PubMed ID: 2558243
[TBL] [Abstract][Full Text] [Related]
25. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer.
Scambia G; Panici PB; Baiocchi G; Perrone L; Iacobelli S; Mancuso S
Anticancer Res; 1988; 8(4):761-4. PubMed ID: 3178164
[TBL] [Abstract][Full Text] [Related]
26. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
Shimizu Y; Akagaki E; Hirota K; Kono M; Miura S; Okudaira Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801
[TBL] [Abstract][Full Text] [Related]
28. Significance of some tumor markers in differential diagnosis of ovarian tumor.
Zakrzewska I; Borawska R; Poznański J; Maćkowiak B
Rocz Akad Med Bialymst; 1999; 44():235-43. PubMed ID: 10697438
[TBL] [Abstract][Full Text] [Related]
29. CA-125 ovarian cancer associated antigen in cancer and pregnancy: interpretation of enzyme immunoassay and immunoradiometric assay.
Touitou Y; Bogdan A; Darbois Y
Anticancer Res; 1989; 9(6):1805-7. PubMed ID: 2697189
[TBL] [Abstract][Full Text] [Related]
30. Is CA-125 monitoring useful in patients with epithelial ovarian carcinoma and preoperative negative CA-125 serum levels?
Sevelda P; Rosen A; Denison U; Barrada M; Spona J; Salzer H
Gynecol Oncol; 1991 Nov; 43(2):154-8. PubMed ID: 1743558
[TBL] [Abstract][Full Text] [Related]
31. CA 125 in peritoneal washings and fluid: correlation with plasma CA 125 and peritoneal cytology.
Schwartz PE; Chambers SK; Chambers JT; Tilton K; Foemmel R
Obstet Gynecol; 1989 Mar; 73(3 Pt 1):339-42. PubMed ID: 2915859
[TBL] [Abstract][Full Text] [Related]
32. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
Schröck R; Hafter R; Schmid L; Babic R; Ulm K; Gössner W; Graeff H
Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679
[TBL] [Abstract][Full Text] [Related]
33. [Clinical applications of CA 125 carcinoma of the ovary].
Tomioka E; Fujita MM; Izaki M; Lin WF; Moriyama AJ; Bastos Ada C
Rev Paul Med; 1991; 109(3):123-30. PubMed ID: 1947608
[TBL] [Abstract][Full Text] [Related]
34. [Ovarian carcinoma antigen (CA 125) and ovarian cancer (clinical follow-up and prognostic studies)].
Göcze P; Vahrson H
Orv Hetil; 1993 Apr; 134(17):915-8. PubMed ID: 8479736
[TBL] [Abstract][Full Text] [Related]
35. The CA 125 tumour-associated antigen: a review of the literature.
Jacobs I; Bast RC
Hum Reprod; 1989 Jan; 4(1):1-12. PubMed ID: 2651469
[TBL] [Abstract][Full Text] [Related]
36. Use of CA 125 monoclonal antibody to monitor patients with ovarian cancer.
Kudlacek S; Schieder K; Kölbl H; Neunteufel W; Nowotny C; Breitenecker G; Biegelmayer G; Vetterlein M; Fürlinger B; Micksche M
Gynecol Oncol; 1989 Dec; 35(3):323-9. PubMed ID: 2480931
[TBL] [Abstract][Full Text] [Related]
37. [CA 125 in the diagnosis and evaluation of the efficacy of the treatment of cancer of the ovaries].
Sagan DL; Chebotareva ED; Evtushenko GV
Med Radiol (Mosk); 1989 Jun; 34(6):39-42. PubMed ID: 2739519
[TBL] [Abstract][Full Text] [Related]
38. [Two cases of tuberculous peritonitis and clinical significance of serum CA-125].
Takeshima F; Hamabe S; Yamasa T; Hiratani K; Hayashi T; Kohno S; Yamaguchi K; Hirota M; Hara K; Matsumoto T
Kekkaku; 1989 Jan; 64(1):25-30. PubMed ID: 2709654
[TBL] [Abstract][Full Text] [Related]
39. CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancer.
Hunter VJ; Weinberg JB; Haney AF; Soper JT; Lavin P; Metsch L; Knapp RC; Bast RC
Gynecol Oncol; 1990 Feb; 36(2):161-5. PubMed ID: 2404835
[TBL] [Abstract][Full Text] [Related]
40. What do CA 125 and other antigens tell us about ovarian cancer biology?
Welander CE
Acta Obstet Gynecol Scand Suppl; 1992; 155():85-93. PubMed ID: 1502896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]